AR-12286 in Combination With Latanoprost
Public ClinicalTrials.gov record NCT01302249. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a double-masked, randomized, multi-center, active-controlled, crossover comparison of the addition of AR-12286 or timolol to latanoprost in the treatment of elevated intraocular pressure (IOP).
Study identification
- NCT ID
- NCT01302249
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Interventions
- Latanoprost 0.005% Drug
- AR-12286 Ophthalmic Solution 0.5% Drug
- Timolol maleate ophthalmic solution 0.5% Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2011 (Type not available)
- Primary completion
- Dec 2011 (Actual)
- Completion
- Dec 2011 (Actual)
- Last update posted
- May 8, 2014
2011
United States locations
- U.S. sites
- 15
- U.S. states
- 13
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| David Silverstone, M.D. | New Haven | Connecticut | 06510 | — |
| Coastal Research Associates, LLC | Roswell | Georgia | 30076 | — |
| Heart of America Eye Care, P.A. | Shawnee Mission | Kansas | 66204 | — |
| Taustine Eye Center | Louisville | Kentucky | 40217 | — |
| Alan L Robin, M.D. | Baltimore | Maryland | 21209 | — |
| Comprehensive Eye Care | St Louis | Missouri | 63090 | — |
| Rochester Ophthalmology Group | Rochester | New York | 14618 | — |
| Glaucoma Consultants of the Capital Region | Slingerlands | New York | 12159 | — |
| Thomas K. Mundorf, M.D. | Charlotte | North Carolina | 28204 | — |
| Charlotte Eye Ear Nose and Throat | Charlotte | North Carolina | 28210 | — |
| The Eye Institute | Tulsa | Oklahoma | 74104 | — |
| Wills Eye Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | — |
| Cataract & Glaucoma Center | El Paso | Texas | 79902 | — |
| Stacy R. Smith, M.D. | Salt Lake City | Utah | 84117 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01302249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2014 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01302249 live on ClinicalTrials.gov.